Capital Southwest Corporation Declares Regular Dividend

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Capital Southwest Corporation Declares Regular Dividend

DALLAS, April 24, 2015 (GLOBE NEWSWIRE) -- The board of directors of Capital Southwest Corporation (Nasdaq: CSWC ), a publicly traded business development company, approved on April 22, 2015 the declaration of a cash dividend in the amount of $0.10 per share of common stock. The dividend is payable on May 29, 2015 to shareholders of record on May 14, 2015.

About Capital Southwest Corporation

Capital Southwest Corporation (Nasdaq: CSWC ) is a Dallas-based publicly traded business development company ("BDC"), with approximately $750 million in assets. On December 2, 2014, Capital Southwest announced its intent to separate into two public companies through the spinoff of certain of its control assets into a diversified industrial growth company and the refocusing of the BDC on lending to strong middle market companies. As a result, our new investment activity is focused on senior "unitranche" debt, second lien and subordinated debt, as well as equity co-investments to support the acquisition and growth of middle market companies. Our control companies, slated to be part of the diversified growth company, are actively seeking growth through strategic acquisitions. Since Capital Southwest was formed in 1961, we have always sought to invest in companies with strong management teams and sound financial performance. As a public company, we are fortunate to have the flexibility to be creative in our financing structures and to invest to support the growth of our portfolio companies with a long-term perspective.

Forward-Looking Statements

This press release may contain historical information and forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 with respect to the business, financial condition and results of operations of Capital Southwest Corporation. Any statements preceded or followed by or that include the words "believe," "expect," "intend," "plan," "should" or words, phrases or similar expressions or the negative thereof, are intended to identify forward-looking statements. These statements are made on the basis of the current beliefs, expectations and assumptions of the management of CSWC. There are a number of risks and uncertainties that could cause CSWC's actual results to differ materially from the forward-looking statements included in this communication. These risks and uncertainties include, but are not limited to, risks relating to changes in the markets in which the Company operates and in general economic and business conditions, CSWC's ability to obtain all necessary approvals to complete, and to otherwise complete, the proposed spin-off transaction and to achieve the expected benefits therefrom. 

In light of these risks, uncertainties, assumptions, and other factors inherent in forward-looking statements, actual results may differ materially from those discussed in this communication. Other unknown or unpredictable factors could also have a material adverse effect on CSWC's actual future results, performance, or achievements. For a further discussion of these and other risks and uncertainties applicable to CSWC and its business, see CSWC's Annual Report on Form 10-K for the fiscal year ended March 31, 2014 and subsequent filings with the Securities and Exchange Commission (the "SEC"). As a result of the foregoing, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this communication. CSWC does not assume any obligation to update these forward-looking statements to reflect any new information, subsequent events or circumstances, or otherwise, except as may be required by law.

Joseph B. Armes 214-884-3820

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Del Monte's Sustainability Report Shows Significant Progress

Updated Category News Views 200

Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...

Continue Reading
MEXC Enhances User Security with New Compliance Measures

Updated Category News Views 118

MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...

Continue Reading
Market Insights: Asian Shares and Economic Influences

Updated Category News Views 154

Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...

Continue Reading
Understanding Recent CPSC Recalls and Safety Measures

Updated Category News Views 280

Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...

Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus

Updated Category News Views 213

Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...

Continue Reading